This inventor holds 5 USPTO granted patents and 6 published patent applications, plus 5 CIPO patents and 5 EPO patents. Top assignee: Novartis Ag. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2025
Title: The Innovative Contributions of Cristina Lopez-Lopez
Introduction
Cristina Lopez-Lopez is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of medical research, particularly in the area of cognitive impairments and neurodegenerative disorders. With a total of 5 patents to her name, her work has the potential to impact therapeutic approaches in treating various cognitive dysfunctions.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment." This invention provides methods for predicting therapeutic responsiveness in subjects suffering from cognitive impairments or dysfunctions, psychotic disorders, and neurodegenerative disorders to an alpha 7 nicotinic acetylcholine receptor activator treatment. This innovative approach aims to enhance the effectiveness of treatments for patients facing these challenging conditions.
Career Highlights
Cristina Lopez-Lopez is currently associated with Novartis AG, a leading global healthcare company. Her role at Novartis allows her to collaborate with other experts in the field and contribute to the development of innovative medical solutions. Her dedication to research and innovation has positioned her as a key figure in her area of expertise.
Collaborations
Cristina has worked alongside notable colleagues, including Donald Johns and Kevin Hall McAllister. These collaborations have further enriched her research and have led to advancements in understanding and treating cognitive disorders.
Conclusion
Cristina Lopez-Lopez's contributions to medical research and her innovative patents highlight her commitment to improving therapeutic outcomes for patients with cognitive impairments. Her work continues to inspire advancements in the field, making her a significant figure in the realm of medical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile